Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.

[1]  Natalia Meani,et al.  Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. , 2005, Blood.

[2]  C. Korgaonkar,et al.  Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function , 2005, Molecular and Cellular Biology.

[3]  Paola Fazi,et al.  Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. , 2005, The New England journal of medicine.

[4]  J. Weber,et al.  ARF Impedes NPM/B23 Shuttling in an Mdm2-Sensitive Tumor Suppressor Pathway , 2004, Molecular and Cellular Biology.

[5]  Xiaoling Zhang,et al.  Hypoxia-induced Nucleophosmin Protects Cell Death through Inhibition of p53* , 2004, Journal of Biological Chemistry.

[6]  Leena Latonen,et al.  Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. , 2004, Cancer cell.

[7]  F. Carrier,et al.  Nucleophosmin Sets a Threshold for p53 Response to UV Radiation , 2004, Molecular and Cellular Biology.

[8]  Charles J. Sherr,et al.  Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23 , 2004, Molecular and Cellular Biology.

[9]  David Hawke,et al.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. , 2003, Molecular cell.

[10]  L. David,et al.  Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR* , 2003, Journal of Biological Chemistry.

[11]  C. Mathew,et al.  Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. , 2003, Blood.

[12]  G. Inghirami,et al.  NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. , 2003, Blood.

[13]  B. Yung,et al.  UV Stimulation of Nucleophosmin/B23 Expression Is an Immediate-early Gene Response Induced by Damaged DNA* , 2002, The Journal of Biological Chemistry.

[14]  R. Redner.  Variations on a theme: the alternate translocations in APL , 2002, Leukemia.

[15]  Pier Giuseppe Pelicci,et al.  Nucleophosmin regulates the stability and transcriptional activity of p53 , 2002, Nature Cell Biology.

[16]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[17]  K. Zeller,et al.  Characterization of Nucleophosmin (B23) as a Myc Target by Scanning Chromatin Immunoprecipitation* , 2001, The Journal of Biological Chemistry.

[18]  D. Green,et al.  Mechanisms of p53-dependent apoptosis. , 2001, Biochemical Society transactions.

[19]  P. Neiman,et al.  Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. T. Kim,et al.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. , 2001, Genes & development.

[21]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[22]  E. Appella,et al.  p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage , 2000, The EMBO journal.

[23]  G. Wahl,et al.  A transactivation-deficient mouse model provides insights into Trp53 regulation and function , 2000, Nature Genetics.

[24]  E. Appella,et al.  Signaling to p53: breaking the posttranslational modification code. , 2000, Pathologie-biologie.

[25]  A. Partin,et al.  Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4‐216) recognizes nucleophosmin/B23 , 1999, The Prostate.

[26]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[27]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[28]  B. Yung,et al.  Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23 , 1998, Oncogene.

[29]  A. Yamaura,et al.  Search for genes involved in UV-resistance in human cells by mRNA differential display: increased transcriptional expression of nucleophosmin and T-plastin genes in association with the resistance. , 1998, Biochemical and biophysical research communications.

[30]  A. Carr,et al.  Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Hsu,et al.  Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells , 1998, Oncogene.

[32]  C. Gerçel-Taylor,et al.  Induction of Immune Responses to Ovarian Tumor Antigens by Multiparity , 1997, The Journal of the Society for Gynecologic Investigation: JSGI.

[33]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[34]  T. Taniguchi,et al.  Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity , 1997, Oncogene.

[35]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[36]  A. Levine,et al.  A functionally inactive p53 protein interatocarcinoma cells is activated by either DNA damage or cellular differentiation , 1996, Nature Medicine.

[37]  C. Chresta,et al.  Oddball p53 in testicular tumors , 1996, Nature Medicine.

[38]  S. Raimondi,et al.  The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.

[39]  W. Dinjens,et al.  EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA , 1996, The Journal of pathology.

[40]  W. Dinjens,et al.  Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. , 1995, European journal of biochemistry.

[41]  S. Patterson,et al.  Reduced Numatrin/B23/Nucleophosmin Labeling in Apoptotic Jurkat T-lymphoblasts (*) , 1995, The Journal of Biological Chemistry.

[42]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[43]  T. Sugimura,et al.  Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. , 1992, Cancer research.

[44]  C. Lehner,et al.  Major nucleolar proteins shuttle between nucleus and cytoplasm , 1989, Cell.

[45]  Qing-Rong Liu,et al.  Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. , 1989, Biochemistry.

[46]  N. Feuerstein,et al.  Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. , 1988, The Journal of biological chemistry.

[47]  N. Feuerstein,et al.  Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. , 1987, Journal of immunology.

[48]  J J Mond,et al.  "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. , 1987, The Journal of biological chemistry.

[49]  Ming H Wu,et al.  Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression. , 2002, Carcinogenesis.